The remaining SNVs detected in HUSE-GBM were located within 7 bp of the positions initially discovered in SweGBM-1, suggesting a common mutational hotspot and reinforcing the idea that these non-coding SNVs may disrupt TF binding and other epigenetic mechanisms, ultimately driving tumor progression. The gene discussed is TF; the disease is neoplasm.